<?xml version="1.0" encoding="UTF-8"?>
<p>While numerous studies are carried out to determine the antifungal activity of EO in vitro, only a few formulations reach the clinical stage and even less become a commercial product. As seen in this review, few clinical trials have been carried out to test experimental formulations containing EO and/or isolated constituents against oral candidiasis. Currently, the most common formulations for the treatment of oral candidiasis are for external use, such as oral solutions, gels, and creams, which are normally safe [
 <xref rid="B71" ref-type="bibr">71</xref>].
</p>
